Medisun Precision Medicine

Medisun Precision Medicine (formerly Accurexa) is a biotechnology company focused on targeted delivery of therapies to affected areas of a patient's body through the use of innovative technologies. It is engaged in developing an ACX-31 program to deliver chemotherapy drugs, temozolomide in combination with BCNU, to brain tumor sites.